Citation 125827

SHAMON,LA: CHEN,C: MEHTA,RG: STEELE,V: MOON,RC: PEZZUTO,JM:. (1994). A CORRELATIVE APPROACH FOR THE IDENTIFICATION OF ANTIMUTAGENS THAT DEMONSTRATE CHEMOPREVENTIVE ACTIVTY.. 14(5A)

Citation Details

Title	A CORRELATIVE APPROACH FOR THE IDENTIFICATION OF ANTIMUTAGENS THAT DEMONSTRATE CHEMOPREVENTIVE ACTIVTY.
Authors	SHAMON,LA: CHEN,C: MEHTA,RG: STEELE,V: MOON,RC: PEZZUTO,JM:
Year	1994
Volume	14
Issue	5A

Summary

Year: 1994

Journal: Unknown

Organisms and Their Experiments (5)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIMUTAGENIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	APIGENIN	ACTIVE
2	CARCINOGENESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	APIGENIN	ACTIVE
3	ANTIMUTAGENIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BRASSININ	ACTIVE
4	CARCINOGENESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BRASSININ	ACTIVE
5	ANTIMUTAGENIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CARBENOXOLONE*	ACTIVE
6	CARCINOGENESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CARBENOXOLONE*	ACTIVE
7	ANTIMUTAGENIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CAROTENE,DELTA:	ACTIVE
8	CARCINOGENESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CAROTENE,DELTA:	ACTIVE
9	ANTIMUTAGENIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,(+):	ACTIVE
10	CARCINOGENESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,(+):	ACTIVE
11	ANTIMUTAGENIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CHLOROPHYLLIN	ACTIVE
12	CARCINOGENESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CHLOROPHYLLIN	ACTIVE
13	ANTIMUTAGENIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CINEOL,1-8:	ACTIVE
14	CARCINOGENESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CINEOL,1-8:	ACTIVE
15	ANTIMUTAGENIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CURCUMIN	ACTIVE
16	CARCINOGENESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CURCUMIN	ACTIVE
17	ANTIMUTAGENIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DIALLYL SULFIDE	ACTIVE
18	CARCINOGENESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DIALLYL SULFIDE	ACTIVE
19	ANTIMUTAGENIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ELLAGIC ACID	ACTIVE
20	CARCINOGENESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ELLAGIC ACID	ACTIVE
21	ANTIMUTAGENIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GALLOCATECHIN-3-O-GALLATE,EPI: (-):	ACTIVE
22	CARCINOGENESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GALLOCATECHIN-3-O-GALLATE,EPI: (-):	ACTIVE
23	ANTIMUTAGENIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	AESCULETIN	ACTIVE
24	CARCINOGENESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	AESCULETIN	ACTIVE
25	ANTIMUTAGENIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FERULIC ACID	ACTIVE
26	CARCINOGENESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FERULIC ACID	ACTIVE
27	ANTIMUTAGENIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GLYCYRRHETINIC ACID	ACTIVE
28	CARCINOGENESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GLYCYRRHETINIC ACID	ACTIVE
29	ANTIMUTAGENIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LIMONENE	ACTIVE
30	CARCINOGENESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LIMONENE	ACTIVE
31	ANTIMUTAGENIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	LYCOPENE	ACTIVE
32	CARCINOGENESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LYCOPENE	ACTIVE
33	ANTIMUTAGENIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	MANNITOL,D:	ACTIVE
34	CARCINOGENESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MANNITOL,D:	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIMUTAGENIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	MELATONIN	ACTIVE
2	CARCINOGENESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MELATONIN	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIMUTAGENIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GUAIARETIC ACID,NOR-DIHYDRO:	ACTIVE
2	CARCINOGENESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	GUAIARETIC ACID,NOR-DIHYDRO:	ACTIVE
3	ANTIMUTAGENIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN	ACTIVE
4	CARCINOGENESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN	ACTIVE
5	ANTIMUTAGENIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SILYMARIN	ACTIVE
6	CARCINOGENESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SILYMARIN	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIMUTAGENIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ALLYL METHYL DISULFIDE	INACTIVE
2	CARCINOGENESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ALLYL METHYL DISULFIDE	INACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIMUTAGENIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	ARGININE,D:	INACTIVE
2	CARCINOGENESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ARGININE,D:	INACTIVE
3	ANTIMUTAGENIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CRYPTOPORIC ACID DCRYPTOPORIC ACID ECOSTUSLACTONE,DEHYDRO:DAIDZEIN	INACTIVE
4	CARCINOGENESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CRYPTOPORIC ACID DCRYPTOPORIC ACID ECOSTUSLACTONE,DEHYDRO:DAIDZEIN	INACTIVE
5	ANTIMUTAGENIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PHENOL,PARA-METHOXY:OCTADEC-9-YNOIC ACIDMORUSINLINOLEIC ACID	INACTIVE
6	CARCINOGENESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHENOL,PARA-METHOXY:OCTADEC-9-YNOIC ACIDMORUSINLINOLEIC ACID	INACTIVE
7	ANTIMUTAGENIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TOCOPHEROL,ALPHA: ACETATEURSOLIC ACIDRUTINPALMITOLEIC ACID	ACTIVE
8	CARCINOGENESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TOCOPHEROL,ALPHA: ACETATEURSOLIC ACIDRUTINPALMITOLEIC ACID	INACTIVE
9	ANTIMUTAGENIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DEGUELIN	INACTIVE
10	CARCINOGENESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DEGUELIN	ACTIVE
11	ANTIMUTAGENIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	METHIONINE,(DL):	INACTIVE
12	CARCINOGENESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	METHIONINE,(DL):	ACTIVE
13	ANTIMUTAGENIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PHYTIC ACID	INACTIVE
14	CARCINOGENESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PHYTIC ACID	ACTIVE
15	ANTIMUTAGENIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TEPHROSIN	INACTIVE
16	CARCINOGENESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TEPHROSIN	ACTIVE
17	ANTIMUTAGENIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CARNOSINE,L:	ACTIVE
18	CARCINOGENESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CARNOSINE,L:	INACTIVE
19	ANTIMUTAGENIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	MENADIONEFISETIN	ACTIVE
20	CARCINOGENESIS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MENADIONEFISETIN	INACTIVE

Citation 125827

Citation Details

Summary

Organisms and Their Experiments (5)

Unknown organism

Unknown organism

Unknown organism

Unknown organism

Unknown organism

Show SPARQL Queries (1)

Query 1